• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症的管理:英国风湿病学会指南范围

Management of systemic sclerosis: British Society for Rheumatology guideline scope.

作者信息

Denton Christopher P, De Lorenzis Enrico, Roblin Elen, Goldman Nina, Alcacer-Pitarch Begonya, Blamont Emma, Buch Maya, Carulli Maresa, Cotton Caroline, Del Galdo Francesco, Derrett-Smith Emma, Douglas Karen, Farrington Sue, Fligelstone Kim, Gompels Luke, Griffiths Bridget, Herrick Ariane, Hughes Michael, Pain Clare, Pantano Georgina, Pauling John, Prabu Athiveeraramapandian, O'Donoghue Nuala, Renzoni Elisabetta, Royle Jeremy, Samaranayaka Muditha, Spierings Julia, Tynan Aoife, Warburton Louise, Ong Voon

机构信息

Centre for Rheumatology, Division of Medicine, University College London, London, UK.

Department of Rheumatology, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

出版信息

Rheumatol Adv Pract. 2023 Mar 14;7(1):rkad022. doi: 10.1093/rap/rkad022. eCollection 2023.

DOI:10.1093/rap/rkad022
PMID:36923262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10010890/
Abstract

This guideline will provide a practical roadmap for management of SSc that builds upon the previous treatment guideline to incorporate advances in evidence-based treatment and increased knowledge about assessment, classification and management. General approaches to management as well as treatment of specific complications will be covered, including lung, cardiac, renal and gastrointestinal tract disease, as well as RP, digital vasculopathy, skin manifestations, calcinosis and impact on quality of life. It will include guidance related to emerging approved therapies for interstitial lung disease and account for National Health Service England prescribing policies and national guidance relevant to SSc. The guideline will be developed using the methods and processes outlined in Creating Clinical Guidelines: Our Protocol. This development process to produce guidance, advice and recommendations for practice has National Institute for Health and Care Excellence accreditation.

摘要

本指南将提供一份系统性硬化症管理的实用路线图,它以先前的治疗指南为基础,纳入循证治疗的进展以及对评估、分类和管理的更多认识。将涵盖一般管理方法以及特定并发症的治疗,包括肺部、心脏、肾脏和胃肠道疾病,以及雷诺现象、指端血管病变、皮肤表现、钙质沉着症和对生活质量的影响。它将包括与间质性肺病新获批疗法相关的指导,并考虑英格兰国民医疗服务体系的处方政策以及与系统性硬化症相关的国家指南。本指南将采用《制定临床指南:我们的方案》中概述的方法和流程来制定。这一为实践提供指导、建议和推荐的制定过程已获得英国国家卫生与临床优化研究所的认可。

相似文献

1
Management of systemic sclerosis: British Society for Rheumatology guideline scope.系统性硬化症的管理:英国风湿病学会指南范围
Rheumatol Adv Pract. 2023 Mar 14;7(1):rkad022. doi: 10.1093/rap/rkad022. eCollection 2023.
2
Management and treatment of children, young people and adults with systemic lupus erythematosus: British Society for Rheumatology guideline scope.儿童、青少年及成人系统性红斑狼疮的管理与治疗:英国风湿病学会指南范围
Rheumatol Adv Pract. 2023 Dec 5;7(3):rkad093. doi: 10.1093/rap/rkad093. eCollection 2023.
3
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis.2024 年英国风湿病学会系统性硬化症管理指南。
Rheumatology (Oxford). 2024 Nov 1;63(11):2956-2975. doi: 10.1093/rheumatology/keae394.
4
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis-executive summary.2024 年英国风湿病学会系统性硬化症管理指南——执行摘要。
Rheumatology (Oxford). 2024 Nov 1;63(11):2948-2955. doi: 10.1093/rheumatology/keae390.
5
Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope.生物制剂和靶向合成 DMARDs 治疗银屑病关节炎:英国风湿病学会指南范围。
Rheumatology (Oxford). 2021 Apr 6;60(4):1588-1592. doi: 10.1093/rheumatology/keaa526.
6
The management of Sjögren's syndrome: British Society for Rheumatology guideline scope.干燥综合征的管理:英国风湿病学会指南范围。
Rheumatology (Oxford). 2021 May 14;60(5):2122-2127. doi: 10.1093/rheumatology/keaa870.
7
Evidence-based management of systemic sclerosis: Navigating recommendations and guidelines.系统性硬化症的循证管理:解读推荐意见与指南
Semin Arthritis Rheum. 2017 Jun;46(6):767-774. doi: 10.1016/j.semarthrit.2016.12.003. Epub 2016 Dec 9.
8
The diagnosis and management of systemic autoimmune rheumatic disease-related interstitial lung disease: British Society for Rheumatology guideline scope.系统性自身免疫性风湿疾病相关间质性肺疾病的诊断与管理:英国风湿病学会指南范围
Rheumatol Adv Pract. 2024 Apr 18;8(2):rkae056. doi: 10.1093/rap/rkae056. eCollection 2024.
9
Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline.系统性硬化症相关间质性肺疾病的治疗:循证推荐。美国胸科学会临床实践指南。
Am J Respir Crit Care Med. 2024 Jan 15;209(2):137-152. doi: 10.1164/rccm.202306-1113ST.
10
Evidence-based guideline: premature ovarian insufficiency.循证指南:卵巢早衰
Hum Reprod Open. 2024 Dec 9;2024(4):hoae065. doi: 10.1093/hropen/hoae065. eCollection 2024.

引用本文的文献

1
A Scleroderma and Raynaud's UK (SRUK) national survey to explore rheumatologists' awareness, approaches to diagnosis and management and training needs within systemic sclerosis.英国硬皮病与雷诺病协会(SRUK)开展的一项全国性调查,旨在探究风湿病专家对系统性硬化症的认知、诊断和管理方法以及培训需求。
Rheumatol Adv Pract. 2024 Dec 20;9(1):rkae152. doi: 10.1093/rap/rkae152. eCollection 2025.
2
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis.2024 年英国风湿病学会系统性硬化症管理指南。
Rheumatology (Oxford). 2024 Nov 1;63(11):2956-2975. doi: 10.1093/rheumatology/keae394.
3
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis-executive summary.2024 年英国风湿病学会系统性硬化症管理指南——执行摘要。
Rheumatology (Oxford). 2024 Nov 1;63(11):2948-2955. doi: 10.1093/rheumatology/keae390.
4
Attitudes and barriers to pulmonary arterial hypertension screening in systemic sclerosis patients: A survey of UK-based rheumatologists.系统性硬化症患者肺动脉高压筛查的态度与障碍:对英国风湿病学家的一项调查
J Scleroderma Relat Disord. 2024 Jun;9(2):99-109. doi: 10.1177/23971983241235708. Epub 2024 Mar 13.
5
Peripheral and ocular microvascular alterations in systemic sclerosis: observations from capillaroscopic assessments, perfusion peripheral analysis, and optical coherence tomography angiography.系统性硬化症的外周和眼部微血管改变:从毛细血管镜评估、血流外周分析和光相干断层扫描血管造影观察到的结果。
Rheumatol Int. 2024 Jan;44(1):107-118. doi: 10.1007/s00296-023-05495-z. Epub 2023 Nov 17.
6
The Impact of Progressive Pulmonary Fibrosis in Systemic Sclerosis-Associated Interstitial Lung Disease.进行性肺纤维化在系统性硬化症相关间质性肺疾病中的影响
J Clin Med. 2023 Oct 23;12(20):6680. doi: 10.3390/jcm12206680.
7
Biomarkers in the Pathogenesis, Diagnosis, and Treatment of Systemic Sclerosis.系统性硬化症发病机制、诊断及治疗中的生物标志物
J Inflamm Res. 2023 Oct 17;16:4633-4660. doi: 10.2147/JIR.S379815. eCollection 2023.

本文引用的文献

1
Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS).雷诺现象患者进展为系统性硬化症:欧洲硬皮病试验与研究组多中心、系统性硬化症极早期诊断纵向注册研究(VEDOSS)的五年分析。
Lancet Rheumatol. 2021 Dec;3(12):e834-e843. doi: 10.1016/S2665-9913(21)00244-7.
2
Systemic Sclerosis-Associated Interstitial Lung Disease: How to Incorporate Two Food and Drug Administration-Approved Therapies in Clinical Practice.系统性硬化症相关间质性肺病:如何在临床实践中纳入两种获得美国食品药品监督管理局批准的疗法。
Arthritis Rheumatol. 2022 Jan;74(1):13-27. doi: 10.1002/art.41933. Epub 2021 Nov 10.
3
Consensus-based recommendations for the management of juvenile systemic sclerosis.基于共识的青少年系统性硬皮病管理建议。
Rheumatology (Oxford). 2021 Apr 6;60(4):1651-1658. doi: 10.1093/rheumatology/keaa584.
4
The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink.英国临床实践研究数据库中系统性硬化症的发病率、患病率和生存率。
Clin Rheumatol. 2018 Aug;37(8):2103-2111. doi: 10.1007/s10067-018-4182-3. Epub 2018 Jun 30.
5
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.欧洲皮肤病论坛 S1 指南:皮肤硬化病的诊断和治疗,第 1 部分:局限性硬皮病、系统性硬皮病和重叠综合征。
J Eur Acad Dermatol Venereol. 2017 Sep;31(9):1401-1424. doi: 10.1111/jdv.14458. Epub 2017 Aug 9.
6
Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS).早期弥漫性皮肤系统性硬化症的治疗结果:欧洲硬皮病观察研究(ESOS)
Ann Rheum Dis. 2017 Jul;76(7):1207-1218. doi: 10.1136/annrheumdis-2016-210503. Epub 2017 Feb 10.
7
Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis.英国系统性硬化症研究小组的共识最佳实践路径:系统性硬化症中心脏病的管理
Rheumatology (Oxford). 2017 Jun 1;56(6):912-921. doi: 10.1093/rheumatology/kew488.
8
Update of EULAR recommendations for the treatment of systemic sclerosis.EULAR 系统性硬皮病治疗推荐更新。
Ann Rheum Dis. 2017 Aug;76(8):1327-1339. doi: 10.1136/annrheumdis-2016-209909. Epub 2016 Nov 9.
9
UK Scleroderma Study Group (UKSSG) guidelines on the diagnosis and management of scleroderma renal crisis.英国硬皮病研究组(UKSSG)关于硬皮病肾危象诊断与管理的指南。
Clin Exp Rheumatol. 2016 Sep-Oct;34 Suppl 100(5):106-109. Epub 2016 Sep 29.
10
Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.系统性硬化症早期器官表现的发病率及危险因素:一项欧洲硬皮病研究与治疗协会(EUSTAR)的纵向研究
PLoS One. 2016 Oct 5;11(10):e0163894. doi: 10.1371/journal.pone.0163894. eCollection 2016.